Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Scherrer

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2009
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failuresAlexandra U Scherrer, Viktor von Wyl, Christof A Fux, et al.
The Journal of Infectious Diseases|November 18, 2021
Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort StudySuraj Balakrishna, Aline Wolfensberger, Viacheslav Kachalov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2011
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype BAlexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, et al.
Plos One|August 31, 2013
Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patternsJörg Schüpbach, Martin D Gebhardt, Alexandra U Scherrer, et al.
The Journal of Infectious Diseases|May 10, 2020
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort StudyJan A Roth, Gorjan Radevski, Catia Marzolini, et al.
International Journal of Cancer|November 14, 2019
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk predictionJean-Damien Combes, Gary M Clifford, Huldrych F Günthard, et al.
The Journal of Infectious Diseases|January 11, 2015
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012Wan-Lin Yang, Roger Kouyos, Alexandra U Scherrer, et al.
Open Forum Infectious Diseases|January 29, 2020
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral TherapyCatalina Barceló, Monia Guidi, Christian W Thorball, et al.
Plos Neglected Tropical Diseases|June 23, 2020
Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysisPiero L Olliaro, Jean T Coulibaly, Amadou Garba, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2015
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort StudyWan-Lin Yang, Roger D Kouyos, Alexandra U Scherrer, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2009
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failuresAlexandra U Scherrer, Viktor von Wyl, Christof A Fux, et al.
The Journal of Infectious Diseases|November 18, 2021
Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort StudySuraj Balakrishna, Aline Wolfensberger, Viacheslav Kachalov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2011
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype BAlexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, et al.
Plos One|August 31, 2013
Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patternsJörg Schüpbach, Martin D Gebhardt, Alexandra U Scherrer, et al.
The Journal of Infectious Diseases|May 10, 2020
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort StudyJan A Roth, Gorjan Radevski, Catia Marzolini, et al.
International Journal of Cancer|November 14, 2019
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk predictionJean-Damien Combes, Gary M Clifford, Huldrych F Günthard, et al.
The Journal of Infectious Diseases|January 11, 2015
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012Wan-Lin Yang, Roger Kouyos, Alexandra U Scherrer, et al.
Open Forum Infectious Diseases|January 29, 2020
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral TherapyCatalina Barceló, Monia Guidi, Christian W Thorball, et al.
Plos Neglected Tropical Diseases|June 23, 2020
Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysisPiero L Olliaro, Jean T Coulibaly, Amadou Garba, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2015
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort StudyWan-Lin Yang, Roger D Kouyos, Alexandra U Scherrer, et al.
Pageof 14